Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe - Gutierrez-Aguirre, C.H.; Cantu-Rodriguez, O.G.; Gonzalez-Llano, O.; Jaime-Perez, J.C.; Mancias-Guerra, C.; Flores-Jimenez, J.A.; Alatorre-Ricardo, J.; Gomez-Almaguer, D. (Biology of Blood & Marrow Transplantation, 2012)